Royal College of Surgeons in Ireland
Browse

Impact of remission from type 2 diabetes on long‑term health outcomes: findings from the Look AHEAD study

Download (952.11 kB)
journal contribution
posted on 2024-01-19, 14:49 authored by Edward GreggEdward Gregg, Haiying Chen, Michael P Bancks, Raoul Manalac, Nisa Maruthur, Medha Munshi, Rena Wing, Look AHEAD Research Group

Aims/hypothesis: We examined the association of attainment of diabetes remission in the context of a 12 year intensive lifestyle intervention with subsequent incidence of chronic kidney disease (CKD) and CVD.

Methods: The Look AHEAD study was a multi-centre RCT comparing the effect of a 12 year intensive lifestyle intervention with that of diabetes support and education on CVD and other long-term health conditions. We compared the incidence of CVD and CKD among 4402 and 4132 participants, respectively, based on achievement and duration of diabetes remission. Participants were 58% female, and had a mean age of 59 years, a duration of diabetes of 6 year and BMI of 35.8 kg/m2. We applied an epidemiological definition of remission: taking no diabetes medications and having HbA1c <48 mmol/mol (6.5%) at a single point in time. We defined high-risk or very high-risk CKD based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, and CVD incidence as any occurrence of non-fatal acute myocardial infarction, stroke, admission for angina or CVD death.

Results: Participants with evidence of any remission during follow-up had a 33% lower rate of CKD (HR 0.67; 95% CI 0.52, 0.87) and a 40% lower rate of the composite CVD measure (HR 0.60; 95% CI 0.47, 0.79) in multivariate analyses adjusting for HbA1c, BP, lipid levels, CVD history, diabetes duration and intervention arm, compared with participants without remission. The magnitude of risk reduction was greatest for participants with evidence of longer-term remission.

Conclusions/interpretation: Participants with type 2 diabetes with evidence of remission had a substantially lower incidence of CKD and CVD, respectively, compared with participants who did not achieve remission. This association may be affected by post-baseline improvements in weight, fitness, HbA1c and LDL-cholesterol.

Trial registration: ClinicalTrials.gov NCT00017953 DATA AVAILABILITY: https://repository.niddk.nih.gov/studies/look-ahead/.

Funding

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases (DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135 and DK56992)

National Institute of Nursing Research

National Center on Minority Health and Health Disparities

NIH Office of Research on Women’s Health

US Centers for Disease Control and Prevention.

Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.

Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719)

Massachusetts General Hospital Mallinckrodt General Clinical Research Center

Massachusetts Institute of Technology General Clinical Research Center (M01RR01066)

Harvard Clinical and Translational Science Center (RR025758-04)

University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051)

Clinical Nutrition Research Unit (P30 DK48520)

University of Tennessee at Memphis General Clinical Research Center (M01RR0021140)

University of Pittsburgh General Clinical Research Center (GCRC) (M01RR000056)

Clinical Translational Research Center funded by Clinical & Translational Science Award UL1 RR 024153 and NIH grant DK 046204

VA Puget Sound Health Care System Medical Research Service

Department of Veterans Affairs

Frederic C. Bartter General Clinical Research Center (M01RR01346)

FedEx Corporation

Health Management Resources

LifeScan Inc. (a Johnson & Johnson Company)

OPTIFAST® of Nestle HealthCare Nutrition Inc.

Hoffmann-La Roche Inc

Abbott Nutrition

Slim-Fast brand of Unilever North America

National Heart Lung and Blood Institute

History

Data Availability Statement

Look AHEAD data are available on request from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) data repository (https://repository.niddk.nih.gov/studies/look-ahead/).

Comments

The original article is available at https://link.springer.com/

Published Citation

Gregg EW, et al. Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study. Diabetologia. 2024

Publication Date

18 Jan 2024

PubMed ID

38233592

Department/Unit

  • School of Population Health

Publisher

Springer Nature

Version

  • Published Version (Version of Record)